Board Meeting Details
The Meeting of the Board of Directors of Jagsonpal Pharmaceuticals Limited is scheduled to be held on Wednesday, October 28, 2026. The agenda includes considering and approving the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended September 30, 2026.
Trading Window Closure
In continuation of the company's previous communication dated September 25, 2026 regarding intimation of closure of Trading Window, the trading window for trading in Securities of the company shall remain closed until October 30, 2026.